Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Implementation of Locoregional Adjuvant Radiotherapy for Breast Cancer in a Rural Healthcare Region: Toxicity Outcomes in the Initial Cohort

CARSTEN NIEDER, JOAKIM RESSHEIM, ELLINOR C. HAUKLAND and BÅRD MANNSÅKER
Anticancer Research February 2022, 42 (2) 923-928; DOI: https://doi.org/10.21873/anticanres.15551
CARSTEN NIEDER
1Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway;
2Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: carsten.nieder@nlsh.no
JOAKIM RESSHEIM
1Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway;
2Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ELLINOR C. HAUKLAND
1Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway;
2Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway;
3SHARE – Center for Resilience in Healthcare, Faculty of Health Sciences, Department of Quality and Health Technology, University of Stavanger, Stavanger, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BÅRD MANNSÅKER
1Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 42 no. 2 923-928
DOI 
https://doi.org/10.21873/anticanres.15551
PubMed 
35093891

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received November 4, 2021
  • Revision received December 1, 2021
  • Accepted December 3, 2021
  • Published online January 29, 2022.

Copyright & Usage 
Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. CARSTEN NIEDER1,2⇑,
  2. JOAKIM RESSHEIM1,2,
  3. ELLINOR C. HAUKLAND1,2,3 and
  4. BÅRD MANNSÅKER1
  1. 1Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway;
  2. 2Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway;
  3. 3SHARE – Center for Resilience in Healthcare, Faculty of Health Sciences, Department of Quality and Health Technology, University of Stavanger, Stavanger, Norway
  1. Correspondence to: Carsten Nieder, Department of Oncology and Palliative Medicine, Nordland Hospital, 8092 Bodø, Norway. Tel: +47 75578449, Fax: +47 75534975, e-mail: carsten.nieder{at}nlsh.no
View Full Text
PreviousNext
Back to top

In this issue

Anticancer Research: 42 (2)
Anticancer Research
Vol. 42, Issue 2
February 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Implementation of Locoregional Adjuvant Radiotherapy for Breast Cancer in a Rural Healthcare Region: Toxicity Outcomes in the Initial Cohort
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 9 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Implementation of Locoregional Adjuvant Radiotherapy for Breast Cancer in a Rural Healthcare Region: Toxicity Outcomes in the Initial Cohort
CARSTEN NIEDER, JOAKIM RESSHEIM, ELLINOR C. HAUKLAND, BÅRD MANNSÅKER
Anticancer Research Feb 2022, 42 (2) 923-928; DOI: 10.21873/anticanres.15551

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Implementation of Locoregional Adjuvant Radiotherapy for Breast Cancer in a Rural Healthcare Region: Toxicity Outcomes in the Initial Cohort
CARSTEN NIEDER, JOAKIM RESSHEIM, ELLINOR C. HAUKLAND, BÅRD MANNSÅKER
Anticancer Research Feb 2022, 42 (2) 923-928; DOI: 10.21873/anticanres.15551
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • A Novel Filtration Membrane for Clustered Circulating Tumor Cell Extraction: A Prospective Feasibility Study
  • Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI)
  • Early Phase Persistent Changes in the White Blood Cell Fraction in Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab: A Multicenter Retrospective Study
Show more Clinical Studies

Similar Articles

Keywords

  • Adjuvant radiation therapy
  • locoregional radiotherapy
  • Breast cancer
  • toxicity
  • side-effects
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire